- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04122677
Performance and Safety of the Polylactic Interference Screw Used in Anterior Cruciate Ligament Reconstructions
The evaluation of the clinical data has demonstrated the conformity of the Polylactic Interference Screw (PIS), with the relevant essential requirements for its use in orthopaedic applications. The Polylactic Interference Screws are intended for tibial and femoral ligament/graft fixation in the case or Anterior Cruciate Ligament (ACL) reconstructions. It has been concluded that the risks associated with the use of the device are acceptable when weighted against the benefits to the patients. In order to improve the clinical data on the PIS, the manufacturer, Biomatlante, decided to assess that the performance and safety of the device are maintained until the reaching of its intended use. In this objective, the goal of this study will be to observe the following parameters:
Objective IKDC score (clinical evaluation) Subjective IKDS score (functional evaluation) Safety (report of any adverse event) Follow-up of the patient's recovery
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Loire
-
Saint-Étienne, Loire, France, 42100
- Centre ORTHEO
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
The study population is considered as all the patients included in the study that meet the inclusion and exclusion criteria.
The study population is composed of 56 patients according to the protocol.
Description
Inclusion Criteria:
- Acute or chronic Anterior Cruciate Ligament deficiency with complete or partial lesion of the anteromedial bundle requiring primary reconstruction of the Anterior Cruciate Ligament with hamstring tendons
- Males or females aged from 18 to 60 years
- No history of surgery on the affected knee
- Patients not under guardianship or judicial protection
- Signature of non opposition form (consent of the patient
Exclusion Criteria:
- History of ligament, meniscal surgery or fracture of the affected knee
- Pregnancy of breastfeeding women
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of the objective International Knee Documentation Committee score before and after surgery
Time Frame: 4 months before surgery / 7 months post-surgery
|
Record of the objective International Knee Documentation Committee score (A = normal, B = almost normal, C = abnormal or D = very abnormal)
|
4 months before surgery / 7 months post-surgery
|
|
Change of the subjective International Knee Documentation Committee score before and after surgery
Time Frame: 4 months before surgery / 7 months post-surgery
|
Record of the subjective International Knee Documentation Committee score (from 1 to 100 where 100 is the best result)
|
4 months before surgery / 7 months post-surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number and precise description of any adverse event during the follow-up
Time Frame: Before surgery until 7 months post-surgery
|
Record and description of any adverse event during the follow-up that reflects the safety of the Polylactic Interference Screw
|
Before surgery until 7 months post-surgery
|
|
Change in the patients recovery
Time Frame: 2 months post-surgery
|
Record of specific items of the Objective International Knee Documentation Committee score reflecting the patients recovery
|
2 months post-surgery
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: François-Xavier FV VERDOT, M.D., Centre ORTHEO
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2018-A03207-48
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.